0001562180-24-000971.txt : 20240202
0001562180-24-000971.hdr.sgml : 20240202
20240202161030
ACCESSION NUMBER: 0001562180-24-000971
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butler John P.
CENTRAL INDEX KEY: 0001591467
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 24591489
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-31
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001591467
Butler John P.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
true
true
false
false
CEO and President
false
Common Stock
2024-01-31
4
A
false
603500.00
0.00
A
2175372.00
D
Common Stock
2024-02-01
4
S
false
46489.00
1.68
D
2128883.00
D
Common Stock
100000.00
I
Held By John Butler GRAT November 2019
Common Stock
59928.00
I
Held by John Butler 2019 GRAT
Common Stock
100000.00
I
Held By Dorothy Butler GRAT November 2019
Common Stock
59928.00
I
Held by Dorothy Butler 2019 GRAT
Stock Option (Right to buy)
1.68
2024-01-31
4
A
false
905200.00
0.00
A
2034-01-31
Common Stock
905200.00
905200.00
D
The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023.
The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
2024-02-02